Cargando…
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report
Autores principales: | Conley, Anthony P., Trinh, Van Anh, Zobniw, Chrystia M., Posey, Kristi, Martinez, Jaime D., Arrieta, Oscar G., Wang, Wei-Lien, Lazar, Alexander J., Somaiah, Neeta, Roszik, Jason, Patel, Shreyaskumar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180844/ https://www.ncbi.nlm.nih.gov/pubmed/30241159 http://dx.doi.org/10.1200/JGO.2017.009993 |
Ejemplares similares
-
Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
por: Schvartsman, Gustavo, et al.
Publicado: (2017) -
MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
por: Conley, Anthony P., et al.
Publicado: (2019) -
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
por: Somaiah, Neeta, et al.
Publicado: (2012) -
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017) -
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
por: Keung, Emily Z., et al.
Publicado: (2018)